-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Eloxx Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2010 to 2022.
- Eloxx Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2023 was $15K, a 28.6% decline year-over-year.
- Eloxx Pharmaceuticals, Inc. Depreciation for the twelve months ending March 31, 2023 was $71K, a 40.3% decline year-over-year.
- Eloxx Pharmaceuticals, Inc. annual Depreciation for 2022 was $77K, a 32.5% decline from 2021.
- Eloxx Pharmaceuticals, Inc. annual Depreciation for 2021 was $114K, a 67.6% increase from 2020.
- Eloxx Pharmaceuticals, Inc. annual Depreciation for 2020 was $68K, a 21.8% decline from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)